The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)

Exclusion criteria

• Contraindications to IN, e.g. known hypersensitivity or allergy to lactose, fish oil or soy lecithin • Severe diarrhoea requiring medical attention • Current treatment with any immunosuppressive drug • In standard practice, pregnant or lactating women are systematically rejected by the surgeon for this surgical procedure. Furthermore, during the pre-surgical anaesthesia consultation, the eligibility of each patient for anaesthesia will be assessed according to the usual criteria and recommendations of the anaesthesia service of the CHUV • Other clinically significant concomitant disease affecting immunity (e.g., severe renal failure, HIV, SLE, transplant recipient, ...) • Inability to follow the procedures of the study, e.g. due psychological disorders, dementia, etc. • Participation in another study with investigational drug within the 30 days preceding and during the present study • Previous enrolment into the current study • Use of IN independently of the study • Enrolment of the investigator, his/her family members, employees and other dependent persons • Emergency procedure (less than 7 days between screening and surgery)